Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On January 7, 2026, Phathom Pharmaceuticals, Inc. (“Phathom” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated January 7, 2026, by and among Phathom Pharmaceuticals